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3008 AE
10-70410Purpose: We have been developing an image-guided single vocal cord irradiation technique to treat patients with
stage T1a glottic carcinoma. In the present study, we compared the dose coverage to the affected vocal cord and the
dose delivered to the organs at risk using conventional, intensity-modulated radiotherapy (IMRT) coplanar, and
IMRT non-coplanar techniques.
Methods and Materials: For 10 patients, conventional treatment plans using two laterally opposed wedged 6-MV
photon beams were calculated in XiO (Elekta-CMS treatment planning system). An in-house IMRT/beam angle
optimization algorithm was used to obtain the coplanar and non-coplanar optimized beam angles. Using these an-
gles, the IMRT plans were generated in Monaco (IMRT treatment planning system, Elekta-CMS) with the imple-
mented Monte Carlo dose calculation algorithm. The organs at risk included the contralateral vocal cord,
arytenoids, swallowing muscles, carotid arteries, and spinal cord. The prescription dose was 66 Gy in 33 fractions.
Results: For the conventional plans and coplanar and non-coplanar IMRT plans, the population-averaged mean
dose ± standard deviation to the planning target volume was 67 ± 1 Gy. The contralateral vocal cord dose was
reduced from 66 ± 1 Gy in the conventional plans to 39 ± 8 Gy and 36 ± 6 Gy in the coplanar and non-coplanar
IMRT plans, respectively. IMRT consistently reduced the doses to the other organs at risk.
Conclusions: Single vocal cord irradiation with IMRT resulted in good target coverage and provided significant
sparing of the critical structures. This has the potential to improve the quality-of-life outcomes after RT and
maintain the same local control rates.
 2012 Elsevier Inc.
Image-guided radiotherapy, Intensity-modulated radiotherapy, Early glottic carcinoma, Normal tissue sparing,
Quality of life.
Open access under the Elsevier OA license.INTRODUCTION
The ultimate goal of radiotherapy (RT) is the total eradication
of tumors while minimizing the toxicity to the surrounding
healthy structures. In early glottic carcinoma treated with
RT, large box fields, using wedged parallel opposed photon
beams, have been used conventionally. The tumor-free contra-
lateral vocal cord, arytenoids, thyroid cartilage, and all mus-
cles responsible for opening and closing the vocal cords
receive the full dose of 66 Gy. In this conventional method,
the swallowing muscles, carotid arteries, thyroid gland, and
thyroid and cricoid cartilages among other structures, are
partly in field. Exposure of these structures to high radiation
doses (fully or partially) could lead to an increased probability
of complications that negatively influence the quality of life of
these patients. Typical complications have involved voice/t requests to: Sarah O. S. Osman, M.Sc., Department of
Oncology, Erasmus Medical Center–Daniel den Hoed
enter, Groene Hilledijk 301, P.O. Box 5201, Rotterdam
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989speech impairment, diet problems (swallowing, trismus), ary-
tenoid edema, an increased risk of strokes, and reduced treat-
ment options for previously irradiated patients (1–3).
Very good local control rates have been obtained with
simple parallel opposed beams used conventionally.
However, efforts should be made to reduce the dose received
by the tumor-free laryngeal structures to reduce the radiation-
related complications in this group of patients. Reducing the
dose received by the organs at risk (OARs) might also help in
increasing the treatment options for patients with second
primary tumors in the vicinity of the treated tumor. In patients
with successfully treated Stage T1a glottic cancer, the inci-
dence of the development of a second primary tumor (com-
monly in the upper aerodigestive track) at 5, 10, and 15
years was reported to be 23%, 44%, and 48.7%, respectively
(4). Given the large radiation treatment fields presently usedPresented, in part, as a poster at the 10th Biennial European So-
ciety for Therapeutic Radiology and Oncology Meeting, Maas-
tricht, The Netherlands, 2009.
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Fig. 1. (Left) Endoscopic photograph of tumor on one vocal cord and (Right) schematic drawing showing delineations of
clinical target volume (CTV) and corresponding planning target volume (PTV).
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been treated surgically with generous surgical margins that
significantly deteriorate the patients’ quality of life after treat-
ment (5).
At the Erasmus Medical Center, we have been developing
a new focused irradiation technique for early glottic cancer.
The introduction of a new technique brings with it the re-
sponsibility of investigating, testing, and verifying all as-
pects of the RT process. The geometric uncertainties must
be reduced and the residual uncertainties accounted for by
ensuring adequate safety margins for treatment planning.
Accurate dose calculation and treatment delivery are also
crucial.
In a previous study, we investigated and quantified the in-
trafraction respiratory motion of the vocal cords using four-
dimensional computed tomography (CT) scans. It was found
that the movement of the vocal cords with breathing is
minimal (6). In another study, it was shown that it is possible
to reduce the interfraction setup errors to submillimeter
values using cone beam CT scans in an on-line correction
protocol (7).
In the present study, we compared the tumor dose cover-
age and dose delivered to the OARs using conventional
parallel opposed fields with dose delivery using computer-
optimized coplanar and non-coplanar beam setups and
intensity-modulated beam profiles. The dose calculations
were performed using a Monte Carlo (MC)-based treatment
planning system (TPS).METHODS AND MATERIALS
Patients, planning CT scans, and delineations
Ten patients who had been conventionally treated for early-stage
glottic carcinoma (Stage T1aN0M0) were included in the present
study. All patients had undergone four-dimensional CT scanning
(Somatom Sensation Open, Siemens Medical Solutions, New
York, NY) before treatment, reconstructed in eight breathingphases. The CT resolution was 111 mm3. For each patient,
the reconstruction representing the local anatomy in its average re-
spiratory position was used for planning. The OARs contoured
were the contralateral (CL) vocal cord, arytenoids, swallowing
muscle at the level of the vocal cords (inferior constrictor muscles
[ICM], ipsilateral and CL strap muscles), carotid arteries, thyroid
and cricoid cartilages, and spinal cord. The craniocaudal extensions
of the contours for these OARs were the C2 and C6 vertebrae.
In Fig. 1, an example of a Stage T1 tumor confined to one vocal
cord is shown, as well as a schematic drawing of the delineation
method used. The clinical target volume (CTV) was defined as
the whole affected vocal cord as a conservative measure.Margins
In line with the International Commission on Radiation
Units and Measurements recommendations, a planning target
volume (PTV) was constructed around the CTV. A standard
margin formula: M ¼ 2:5Stot þ 1:64stot  1:64sp, where
P
tot¼ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃP2
intrafractionþ
P2
interfraction
q
; stot¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s2intrafractionþs2intrafractionþs2p
q
and sp is the standard deviation describing the penumbra width,
was used (8). The mean penumbra width was 0.4 cm (the smallest
distance between the 95% and 50% isodose lines in the plans). Us-
ing the CT scan with the tumor in its average position for planning,
the systematic respiratory error could be reduced to nearly 0, and
the respiratory motion contribution to the margins stemmed from
purely random errors. We included the uncertainties from the intra-
fraction respiration (6), and the residual interfraction setup errors
(assuming on-line setup corrections to be performed), as measured
and explained in our previously published study (7). For prolonged
treatment sessions ($15 min), the effects of the intrafraction setup
errors might not be negligible and should be accounted for (9). Nev-
ertheless, it has generally been agreed that the magnitude of the in-
trafraction setup errors will be less than that of the interfractional
setup errors (10). In the present study, the intrafraction setup uncer-
tainties were estimated to be equal to the interfraction uncertainties
as a reasonable (upper limit) estimate. Using this procedure, mar-
gins of 0.5, 1.7, and 0.8 mm in the mediolateral, craniocaudal,
and anteroposterior directions were calculated. Given the 1mm3
Table 1. Wish list used in iCycle showing constraints and
objectives used in optimization
Constraint
Volume Type Limit (Gy)
PTV Minimum 63
PTV Maximum 68
Spinal cord Maximum 45
Unspecified tissue Maximum 70
Priority
Objective
Volume Type Goal (Gy)
1 CL vocal cord Mean 30
2 CL arytenoid Mean 50
3 Ipsilateral arytenoid Mean 66
4 ICM Mean 26
5 Unspecified tissue Minimal EUD 10
Abbreviations: PTV = planning target volume; CL = contralat-
eral; ICM= inferior constrictor muscles; EUD= equivalent uniform
dose.
IMRT for single vocal cord RT d S. O. S. OSMAN et al. 991resolution of the CT scan, practical margins of 2 mm in three-
dimensions were used for the present study.Treatment plans
Conventional plans. Conventional clinical treatment plans using
two laterally opposed wedged photon beams were performed using
the XiO TPS (version 4.33, Elekta-CMS). The superior border of
the treatment fields was the hyoid bone, and the inferior border
was the lower edge of the cricoid cartilage. The fields were 1
cm ‘‘falling off’’ anteriorly, and the posterior border was at the an-
terior vertebrae (11). The prescribed dose to the ‘‘box’’ outlined by
the treatment fields was 66 Gy at the 100% isodose, given in 33
fractions at six fractions weekly. The dose was calculated using
the fast superposition algorithm in XiO.
Design of IMRT plans and optimization procedure. An in-
house–developed IMRT/beam angle optimization algorithm
(iCycle) was used to obtain the beam angles for each patient using
a set of standardized constraints and objectives (12). iCycle uses
a list with constraints and prioritized objectives (a ‘‘wish list’’) for
beam angle optimization (Table 1). The constraints were hard and
must be fulfilled at all times. The objectives were processed in pri-
ority. The highest prioritzed objective was to minimize the mean
dose to the CL vocal cord to an acceptable level of 30 Gy (i.e., its
‘‘goal’’). The second priority was to minimize the mean dose to
the CL arytenoid to an acceptable level of 50 Gy, and so forth for
the ipsilateral arytenoid, ICM, and unspecified tissue. The list was
processed in 2 phases. In the first phase, it sought to attain the goals
as well as possible. In the second phase, the objectives for which the
goal could be attained were minimized to their fullest. From this
wish list, iCycle sequentially adds beams to the plan to a maximum
of five beams.
The optimized iCycle beam angles were then imported into the
Monaco TPS, version 1.00 (Elekta-CMS) to generate plans with
a MC dose calculation algorithm. In the Monaco TPS, the plans
were configured using biological and physical constraints (13–
15). For the PTV, a Poisson cell kill model was used combined
with a quadratic overdose constraint to avoid hot spots inside the
PTV. For the CL vocal cord and the spinal cord, serialcomplication models were used to limit the maximal dose to both
structures. Quadratic overdose constraints were also applied to
limit the dose to unspecified tissue. The beams were then
segmented, and their weights were optimized in the second
optimization phase using a photon MC dose engine (XVMC)
based on the voxel MC code (16).
All calculations for the IMRT plans were done for 6-MV photons
with a calculation grid spacing of 1.5 mm. The accelerator used was
an Elekta Synergy with 40 multileaf collimator leaf pairs, and the
leaf width at the isocenter was 4 mm (Elekta Beam Modulator,
Elekta Oncology Systems, Crawley, UK). The minimal segment
size allowed was 0.5 cm2. The isocenter was set to the center of
the CTV. The dose prescribed to the PTV was 66 Gy, given in 33
fractions (six fractions weekly) using the clinical fractionation
scheme. The PTV partially consist of air. No dose was deposited
in that part of the PTV. The Monaco TPS feature ‘‘auto flash’’ cre-
ates a flash margin of the voxels that extends beyond the surface of
the patient (into the air cavity in this case) so that the prescribed
dose can be achieved. A ‘‘flash margin’’ of 2 mm around the PTV
was used in planning. Thus, dose coverage was also provided for
the moving vocal cord (CTV) in and out of the air gap during
breathing and in the case of setup errors.
Plan evaluation. The population-averaged dose–volume histo-
grams (DVH), mean doses, and, in some cases, maximal doses
were used to evaluate and compare the different plans. For the
CTVand selected OARs, the generalized equivalent uniform doses
[EUD(a)] (17) were calculated and compared for the different plan-
ning techniques. The values of the tissue-specific parameter a used
for the CTV were a = 5 and a = 20, because no clear data are
available about the values that should be used for these tumors.
For the OAR, a = 2.2 was used, as recently recommended by Ran-
cati et al. (2). Statistical analysis was performed in MatLab using
pairwise Wilcoxon signed-rank tests at a significance level of p
# .05. Separate analyses were performed to compare conventional
planning with the IMRT coplanar plans and to compare the IMRT
coplanar and IMRT non-coplanar plans; no multiple comparison
was performed. The fractional volumes of the PTV and CTV that
received $95% of the prescription dose were also reported. For
the OARs, the population-averaged mean doses ( standard devia-
tion) and the maximal doses to the spinal cord and carotid arteries
were reported. It has been recommended to keep the dose in the lar-
ynx less than 66 Gy for vocal function preservation (2). There-
fore, the volume of the CL vocal cord that received $95% of the
prescribed dose or more was also reported. It has also been recom-
mended to limit the mean dose to the non-involved larynx to 40 Gy,
because the published data have indicated threshold doses of 40–45
Gy for the onset of other functional complaints (2, 18). Therefore,
we have also reported the fraction of the volume of the CL vocal
cord that received a dose of 40 Gy. Furthermore, the volume of
the carotid arteries that received $35 Gy are also reported,
because reports have been published of complications with
carotid doses 35 Gy (3).RESULTS
iCycle optimized coplanar and non-coplanar beam angles
For each patient, a coplanar and non-coplanar set of opti-
mized beam angles was obtained. The distribution of the
iCycle beam angles for the 10 coplanar plans is shown in
Fig. 2 for tumors on the left vocal cord. Generally, anterior
beams have been favored with a wide range of angles. The
class solution beam angles used were indicated with
Fig. 2. iCycle coplanar beam distributions for left vocal cord tu-
mor. Optimized angles for right side tumors have been mirrored
for this representation. Thicker lines indicate directions chosen
more than once. Class solution angles shown in red with asterisk.
992 I. J. Radiation Oncology d Biology d Physics Volume 82, Number 2, 2012asterisks. Non-coplanar iCycle optimized beam angles are
presented in Table 2.Conventional technique vs. coplanar and non-coplanar
IMRT
The beam setups obtained with iCycle were used to plan
the treatments in the Monaco TPS. Because of the observed
similarity in the selected beam angles for the patients
(Fig. 2), we selected one set of five beam angles and tested
whether this could be used as a class solution for all patients.
This could serve for the simplicity and standardization of
treatment delivery in practice. For patients with tumor on
the left vocal cord, beam angles of 30, 85, 320, 335,
and 350 were used. For those with right vocal cord tumors,
mirrored angles were used. Figure 3 shows the comparisons
between doses received by the different structures, using the
individualized beam arrangement and the class solution. No
significant differences in the delivered doses to the different
structures were observed (all p > 0.05). This could have been
a result of the degeneracy of the solution space (12, 19).
Although not significant, the class solution seemed toTable 2. iCycle individualized non
Beam P1 (Left) P2 (Left) P3 (Left) P4 (Right) P5 (Right)
1 330, 0 345, 0 33, 22 23, 333 16, 342
2 15, 270 344, 289 342, 56 18, 56 344, 289
3 54, 341 334, 37 339, 346 36, 351 37, 17
4 319, 352 37, 343 27, 22 323, 17 313, 346
5 337, 333 329, 10 330, 0 54, 341 34, 333
Abbreviation: P = patient.
Data presented as (gantry, couch) angles; gantry and couch rotate clocresult in somewhat better sparing for some OARs. This
could have resulted from the different dose calculation
algorithms used; the pencil beam algorithm without
adequate MLC segmentation in iCycle in which optimized
IMRT beam angles were generated, and in Monaco, with
a MC-based dose engine and full MLC segmentation. For
the sake of simplicity, all the following results for coplanar
IMRT plans were produced with the proposed class solution.
For non-coplanar plans, the individualized beam angles, as
obtained using iCycle (Table 2), were planned in Monaco,
because it was more complicated to cluster the beam and
couch angles.
Figure 4 shows the dosimetric comparisons among the
conventional, coplanar IMRT, and non-coplanar IMRT
plans. Comparing the conventional plans with the IMRT co-
planar plans, similar mean doses to the CTV (p = 0.2) and
PTV (p = 0.1) were obtained with both techniques. Further-
more, almost all OARs (CL vocal cord, CL arytenoid, ca-
rotid arteries, ICM, thyroid, cricoid, and strap muscles)
were significantly spared with the IMRT plans compared
with the conventional plans (all p = 0.002, except for the ip-
silateral carotid arteries p = 0.004). The PTV extended to
partially cover the ipsilateral arytenoids. Accordingly, doses
similar to the conventionally delivered doses were achieved
using IMRT (p = 0.4). Compared with coplanar IMRT, only
the CL arytenoid was spared more when using non-coplanar
beams (p = 0.01).
For coplanar IMRT plans, the smallest field size was
22.25 cm2, and each plan had on average four segments/
beam. The average number of monitor units required to de-
liver the dose was 441  81. Similarly, for non-coplanar
plans, an average of four segments/beam was used, and the
smallest field size was 22 cm2. The average number of
monitor units was 509  145.
In Fig. 5, a typical example of the dose distributions of
a conventional plan and IMRT coplanar and non-coplanar
setups are shown for 1 patient. The superiority of single vo-
cal cord irradiation (SVCI) is clearly visible. This was also
evident in Fig. 6, in which the population mean DVHs for
the different planning techniques are presented.
For the CTV, CL vocal cord, and the arytenoids, the EUD
mean values ( standard deviation) obtained from the differ-
ent planning techniques are presented in Table 3. The data
show substantial and statistically significant sparing of the
CL vocal cord and CL arytenoid for SCVI with IMRT. The
EUD(5) and EUD(20) for the CTV were slightly (but-coplanar beam arrangements
P6 (Right) P7 (Right) P8 (Right) P9 (Right) P10 (Right)
15, 0 23, 333 16, 342 10, 0 25, 0
344, 71 0, 0 15, 90 44, 338 344, 71
30, 31 36, 9 26, 12 15, 270 36, 9
296, 17 301, 18 306, 19 284, 5 284, 5
49, 340 27, 22 22, 315 18, 34 26, 323
kwise.
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Fig. 3. Mean/maximal doses to different structures from coplanar individualized (iCycle) beam angles and for class so-
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IMRT for single vocal cord RT d S. O. S. OSMAN et al. 993statistically significantly) elevated in the IMRT plans com-
pared with the conventional plans, showing that the large re-
duction in OAR doses with IMRT could be obtained while
also giving a slightly greater dose to the CTV. Several
dose–volume parameters for the CTVs and the contralateral
vocal cord are listed in Table 4. The percentage of the CTV
receiving $95% of the dose was, for all plans,$99%. Only
86% and 88% of the PTV received $95% of the prescribed
dose in the coplanar and non-coplanar plans (see PTV DVH
in Fig. 6). This is due to the fact that the PTVextends into the
air gap of the larynx. Applying a flash margin (see the
‘‘Methods and Materials’’ section), similar fluences were de-
posited to the PTV (i.e., opening the leaves to conform to
a virtual target). The whole CL vocal cord received $95%
of the prescribed dose in the current conventional plans;
however, in the IMRT plans, only a small fractional volume
received such high doses.
On average, the percentage of the volume of the carotid
arteries that received a dose of $35 Gy in the clinical plans
was 86% for the ipsilateral carotid and 92% for the CL ca-
rotid artery. However, a major reduction in the dose received
to both carotid arteries was achieved using SVC IMRT be-
cause no parts of the arteries received any dose >35 Gy
(see also the maximal dose to the carotid arteries in Fig. 4
and the DVHs in Fig. 6).DISCUSSION
We have conducted a planning study for one-sided early
glottic cancer to compare the conventional RT technique (us-
ing wedged parallel opposed fields) with highly focused
IMRT. Although IMRT might not be necessary to controlearly-stage squamous cell carcinoma of the larynx, the
added value of normal tissue sparing has made it clinically
relevant. We found the dose received by healthy structures
in the vicinity of targets can be significantly reduced with
the proposed technique without compromising the target
coverage (Tables 3 and 4 and Fig. 4).
In the present report, we have proposed a class solution for
coplanar beam angles to be used as a template for SVCI in
the treatment of early-stage glottic cancer. This class solu-
tion was derived from full IMRT/beam angle optimization
for the patients in the present study using an in-house–devel-
oped optimizer. Comparing the dose parameters for the dif-
ferent OARs using the individualized plans with respect to
the proposed class solution, little difference was found, sug-
gesting that the class solution is a valid template (Fig. 3). Us-
ing this class solution will reduce the complexity and allow
quicker plan generation compared with individualized beam
setups. Adding non-coplanar beams resulted in little im-
provement in plan quality (Fig. 4). Having non-coplanar
beams would significantly increase the treatment time com-
pared with coplanar treatment. Moreover, it will introduce
positioning difficulties that might not be justified by the
small gain in OAR dose reduction.
As demonstrated in Fig. 4 and Table 3, SVCI results in
major sparing of the CL vocal cord, CL arytenoid, ICM,
strap muscles, thyroid and cricoid cartilages, and carotid ar-
teries compared with conventional RT. For the ipsilateral ar-
ytenoid and anterior commissure, we allowed high doses
(similar to that with the conventional plans) to avoid target
underdosage. For the IMRT plans, the dose to the spinal
cord increased with respect to the conventional plans but
remained far below the specified limit of 45 Gy.
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analysis of the target coverage using the PTV concept would
be inaccurate for SVCI because of the air present in the vol-
ume. The use of the flash margin should guarantee proper
target dose delivery in the case of motion. This is a topic
for additional investigation.
Although RTwas reported superior to laser surgery in terms
of voice preservation, a number of studies have reported that
the voice does not return to normal after RT (20, 21). Other
studies comparing laser surgery and RT as treatment options
reported comparable local control and voice quality
outcomes from the two treatment modalities (22). These stud-Fig. 5. Transverse views at isocenter level for 1 patient sho
modulated radiotherapy (B) coplanar (class solution), and (C)ies compared RT techniques using conventional ‘‘box’’ RT
fields (with high doses to all structures included) with local-
ized laser surgery. This provided a strong motive to hypothe-
size that more focused RT techniques could provide better
results in terms of quality of life compared with laser surgery.
It could also provide better local control among this group of
patients by offering the potential for dose escalation. The in-
creased sparing of the OARs might also allow the application
of hypofractionation schemes to reduce the overall treatment
time and increase patient comfort.
It has generally been agreed that reducing the doses to the
laryngeal structures has the potential to reduce thewing dose distributions for (A) conventional, intensity-
non-coplanar plans.
Fig. 6. Population mean dose–volume histograms from different planning techniques shown for selected structures.
Shaded areas indicate ranges (population minimal and maximal dose–volume histograms). Asterisk indicates partially
contoured organs at risk. CL = contralateral; IL = ipsilateral; m = muscle; ICM = inferior constrictor muscle.
IMRT for single vocal cord RT d S. O. S. OSMAN et al. 995complications related to RT (e.g., swallowing, speech, per-
sistent edema) (1, 2, 23). More recent studies have also
highlighted the increased risk of strokes and direct carotid
artery injury that could result from high-dose irradiation of
the carotid arteries (usually 66 Gy) (3, 24). Both groups
showed a huge reduction of the dose to the carotid arteries
when using IMRT for early glottic carcinoma, which was
confirmed by our study. Limiting the dose to the carotid
arteries might also allow re-irradiation when necessary.
Several groups have opposed the use of IMRT for early
glottic cancer (25, 26). Their main concern has been that
the use of IMRT will compromise local control by failing
to deliver adequate doses to a small primary cancer that
conventional approaches cannot miss. Another concern has
been the limitations of the calculation algorithms that can
result in over- or underdosage at the tissue–air interface.Special attention should also be paid to the potential
enhanced occurrence of second primaries with the small
fields used in SVCI, because evidence has shown that RT
might delay the occurrence of these second tumors (27).
All these valid points were carefully taken into consider-
ation in the present study of SVCI. We have proposed that
with the introduction of on-line image-guided RT and the
availability of more accurate calculation algorithms in com-
mercially available TPSs, the reduction of the treated vol-
umes is a reasonable step to undertake. In contrast to all
previous studies, we defined the CTV (thewhole affected vo-
cal cord) contoured on the CT scans with 1-mm3 resolution.
The intra- and interfractional setup errors have been thor-
oughly investigated, quantified, and reduced (6, 7).
Residual geometric errors were used to construct the CTV-
PTV safety margins. The dose was calculated using MC in
Table 3. Generalized equivalent uniform dose parameters for different plans
Variable Conventional plans IMRT coplanar p* IMRT non-coplanar py
CTV
EUD(5) 67.6  1.0 68.6  0.3 0.03z 68.3  0.8 0.3
EUD(20) 67.6  1.0 68.4  0.3 0.05z 68.0  0.9 0.3
CL vocal cord
EUD(2.2) 67.3  1.0 41.2  5.7 0.002z 40.2  5.7 0.3
Ipsilateral arytenoid
EUD(2.2) 66.2  1.4 63.9  3.9 0.3 65.1  1.7 0.3
CL arytenoid
EUD(2.2) 66.2  1.7 22.1  8.6 0.002z 12.6  4.1 0.01z
Abbreviations: IMRT = intensity-modulated radiotherapy; CTV = clinical target volume; EUD = equivalent uniform dose; CL = contra-
lateral.
* Conventional vs. IMRT coplanar plans.
y Coplanar vs. non-coplanar plans.
z Statistically significant.
996 I. J. Radiation Oncology d Biology d Physics Volume 82, Number 2, 2012the Monaco TPS. The results in the present study indicated
a tremendous reduction in the doses received by the OARs
using the SVCI technique.
In preparation for the SVCI -IMRT technique we have in-
troduced, studies on the dosimetry and dose modeling, espe-
cially in the buildup region, must be carefully conducted. In
our clinic, some of the IMRT beams from the presented plans
were verified using a two-dimensional detector array (15).
Gamma analyses showed good agreement between the
dose distributions calculated using the Monaco TPS and
the measured distributions. Before the clinical introduction
of this treatment, more extensive studies on the accuracy
of the dose engine near tissue inhomogeneities will be con-
ducted. SVCI should be considered an experimental tech-
nique that has yet to be clinically proven. We believe that
SVCI should not be applied outside well-controlled clinical
studies to prove its efficacy. The extremely high-treatment
precision required can only be guaranteed with daily
on-line image-guided RT protocols, advanced dose-Table 4. Dosimetric parameters for CTV and contralat
Variable Conventional plans IMRT cop
CTV
V95%
Mean  SD 100.0  0.0 99.9  0
Range 100–100 99.4–10
Median 100.0 100.0
CL vocal cord
V95%
Mean  SD 100.0  0.0 8.1  6
Range 100.0 100.0 2.0 1
Median 100.0 5.8
V40Gy
Mean  SD 100.0  0.0 39.9  1
Range 100.0 100.0 19.2 6
Median 100.0 38.5
Abbreviations:V95% = fractional volume that received$95% of prescri
$40 Gy.
* Conventional vs. IMRT coplanar plans.
y Coplanar vs. non-coplanar plans.
z Statistically significant.calculation engines, and a very extensive quality assurance
program conducted by experienced personnel.CONCLUSION
Evidence was found that image-guided SVCI using IMRT
can provide significant sparing of critical structures without
compromising CTV coverage, thus offering the possibility
of better voice and swallowing function preservation. A
huge reduction in the maximal dose received by the carotid
arteries was also observed. This has the potential to reduce
the risk of stroke and might also allow re-irradiation (if the
need arises because of second primaries in the vicinity), es-
pecially in younger patients. A class solution of beam angles
was presented to ease and standardize treatment planning for
a single vocal cord. The proposed technique also offers the
new possibilities of dose escalation and hypofractionation
for this group of patients.eral vocal cord for different planning techniques
lanar p*
IMRT
non-coplanar py
1.0 0.5
.2 99.6  0.9
0.0 97.4 100.0
100.0
0.004z 0.6
.5 8.5  6.7
9.4 3.0 20.2
6.3
0.002z 0.5
4.5 38.0  15.3
5.4 22.0 72.4
34.0
ption dose; SD = standard deviation; V40Gy = volume receiving dose
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